Skip to main content
Log in

The contribution of tryptamine to the behavioural effects of l-tryptophan in tranylcypromine-treated rats

  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rats pretreated with the monoamine oxidase inhibitor tranylcypromine and given l-tryptophan develop a characteristic behavioural syndrome. A comparison of the behavioural effects of tranylcypromine plus l-tryptophan (50 and 100 mg/kg) showed a small increase in locomotor activity and a greater increase in the behavioural score with the higher dose. This was associated with a proportionately smaller increase in brain 5-hydroxytryptamine (5-HT) than in brain tryptamine and no change in spinal cord 5-HT. Tryptamine (1–5 mg/kg) in the presence of tranylcypromine produced behavioural effects very similar to those occurring when l-tryptophan is given to tranylcypromine-pretreated rats. Increasing brain tryptamine, by the injection of tryptamine (0.75 mg/kg), enhanced the behavioural effects of tranylcypromine plus l-tryptophan (50 mg/kg) without altering brain 5-HT. Para-chlorophenylalanine pretreatment, which reduced brain 5-HT, prevented the behavioural effects of tryptamine. Inhibition of peripheral decarboxylase with R04-4602 (50 mg/kg) reduced brain tryptamine and did not alter brain 5-HT, but reduced the locomotor activity and the behavioural score of rats given tranylcypromine and l-tryptophan (100 mg/kg). The results suggest that brain tryptamine changes are partly responsible for the behavioural effects of tranylcypromine plus l-tryptophan and that some of this tryptamine is of extracerebral origin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bartholini, G., Burkhard, W. P., Pletscher, A., Bates, H. M.: Increase in cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature 215, 852–853 (1967)

    Google Scholar 

  • Crow, T. J., Deakin, J. F. W.: Role of tryptaminergic mechanisms in elements of the behavioural syndrome evoked by tryptophan and monoamine oxidase inhibitor. Br. J. Pharmacol. 59, 461P (1977)

  • Curzon, G., Joseph, M. H., Knott, P. J.: Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J. Neurochem. 19, 1967–1974 (1972)

    Google Scholar 

  • Foldes, A., Costa, E.: Relationship of brain monoamine and locomotor activity in rats. Biochem. Pharmacol. 24, 1617–1621 (1975)

    Google Scholar 

  • Grahame-Smith, D. G.: Studies in vivo on the relationship between brain tryptophan, brain 5HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and l-tryptophan. J. Neurochem. 18, 1053–1066 (1971)

    Google Scholar 

  • Green, A. R., Grahame-Smith, D. G.: The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Neuropharmacology 13, 949–959 (1974)

    Google Scholar 

  • Green, A. R., Grahame-Smith, D. G.: Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature 260, 487–491 (1976)

    Google Scholar 

  • Green, H., Sawyer, J. L.: Correlation of tryptamine-induced convulsions in rats with brain tryptamine concentration. Proc. Soc. Exp. Biol. Med. 104, 153–155 (1960)

    Google Scholar 

  • Hess, S. M., Doepfner, W.: Behavioural effects and brain amine content in rats. Arch. Int. Pharmacodyn. Ther. 134, 89–99 (1961)

    Google Scholar 

  • Horn, A. S.: Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues. J. Neurochem. 21, 883–888 (1973)

    Google Scholar 

  • Jacobs, B. L.: Evidence for the functional interaction of two central neurotransmitters. Psychopharmacologia (Berl.) 39, 81–86 (1974)

    Google Scholar 

  • Jacobs, B. L., Klemfuss, H.: Brain stem and spinal cord mediation of a serotonergic behavioural syndrome. Brain Res. 100, 450–457 (1975)

    Google Scholar 

  • Marsden, C. A., Curzon, G.: Effects of lesions and drugs on brain tryptamine. J. Neurochem. 23, 1171–1176 (1974)

    Google Scholar 

  • Modigh, K.: Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice. Psychopharmacologia (Berl.) 23, 48–54 (1972)

    Google Scholar 

  • Saavedra, J. M., Axelrod, J.: Effect of drugs on the tryptamine content of rat tissues. J. Pharmacol. Exp. Ther. 185, 523–529 (1973)

    Google Scholar 

  • Sloan, J. W., Martin, W. R., Clements, T. H., Buchwald, W. F., Bridges, S. R.: Factors influencing brain and tissue levels of tryptamine: species, drugs and lesions. J. Neurochem. 24, 523–532 (1975)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marsden, C.A., Curzon, G. The contribution of tryptamine to the behavioural effects of l-tryptophan in tranylcypromine-treated rats. Psychopharmacology 57, 71–76 (1978). https://doi.org/10.1007/BF00426960

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00426960

Key words

Navigation